[HTML][HTML] PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma

X Li, C Wu, N Chen, H Gu, A Yen, L Cao, E Wang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Glioblastoma multiform (GBM) is the most common malignant glioma of all the brain tumors
and currently effective treatment options are still lacking. GBM is frequently accompanied …

Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy

B Marengo, M Nitti, AL Furfaro, R Colla… - Oxidative medicine …, 2016 - Wiley Online Library
Reactive oxygen species (ROS) and their products are components of cell signaling
pathways and play important roles in cellular physiology and pathophysiology. Under …

PI3K/Akt signaling in osteosarcoma

J Zhang, XH Yu, YG Yan, C Wang, WJ Wang - Clinica chimica acta, 2015 - Elsevier
Osteosarcoma (OS) is the most common nonhematologic bone malignancy in children and
adolescents. Despite the advances of adjuvant chemotherapy and significant improvement …

Physiological stimuli induce PAD4-dependent, ROS-independent NETosis, with early and late events controlled by discrete signaling pathways

O Tatsiy, PP McDonald - Frontiers in immunology, 2018 - frontiersin.org
Neutrophils are known to extrude decondensed chromatin, thus forming NETs (neutrophil
extracellular traps). These structures immobilize pathogens, thereby preventing their …

[HTML][HTML] Targeting the PI3K/Akt/mTOR pathway–beyond rapalogs

B Markman, R Dienstmann, J Tabernero - Oncotarget, 2010 - ncbi.nlm.nih.gov
It is well established that the PI3K pathway plays a central role in various cellular processes
that can contribute to the malignant phenotype. Accordingly, pharmacological inhibition of …

[HTML][HTML] Targeting the PI3K-AKT-mTOR signaling network in cancer

KH Khan, TA Yap, L Yan… - Chinese journal of cancer, 2013 - ncbi.nlm.nih.gov
Abstract The phosphoinositide 3-kinase-AKT-mammalian target of rapamycin (PI3K-AKT-
mTOR) pathway is a frequently hyperactivated pathway in cancer and is important for tumor …

Targeting PI3 kinase/AKT/mTOR signaling in cancer

K Sheppard, KM Kinross, B Solomon… - Critical Reviews™ in …, 2012 - dl.begellhouse.com
The phosphatidylinositol 3 kinase (PI3K) pathway is one of the major pathways modulating
cell growth, proliferation, metabolism, survival, and angiogenesis. Hyperactivation of this …

PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes

I Pal, M Mandal - Acta Pharmacologica Sinica, 2012 - nature.com
Abstract The PI3K-Akt pathway is a vital regulator of cell proliferation and survival.
Alterations in the PIK3CA gene that lead to enhanced PI3K kinase activity have been …

Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies

D Barrett, VI Brown, SA Grupp, DT Teachey - Pediatric Drugs, 2012 - Springer
Abstract The phosphatidylinositiol 3-kinase (PI3K), AKT, mammalian target of rapamycin
(mTOR) signaling pathway (PI3K/AKT/mTOR) is frequently dysregulated in disorders of cell …

eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206

Y Cheng, X Ren, Y Zhang, R Patel, A Sharma, H Wu… - Cancer research, 2011 - AACR
Inhibition of the survival kinase Akt can trigger apoptosis, and also has been found to
activate autophagy, which may confound tumor attack. In this study, we investigated …